83 related articles for article (PubMed ID: 2775839)
21. NMR and computer-aided modeling studies of the interactions between a cyclic hexapeptide and the two enantiomers of some Boc- and Fmoc-amino acids.
McEwen I
Biopolymers; 1993 Jun; 33(6):933-42. PubMed ID: 8318666
[TBL] [Abstract][Full Text] [Related]
22. Conformational studies of cyclic enkephalin analogues with L- or D-proline in position 3.
Malicka J; Groth M; Czaplewski C; Wiczk W; Liwo A
Biopolymers; 2002 Apr; 63(4):217-31. PubMed ID: 11807749
[TBL] [Abstract][Full Text] [Related]
23. Conformations of cyclic octapeptides. 4. Diastereomers of cyclo(Gly-Pro-Phe-Ala-Asn-Ala-Val-Ser).
Vishwanath CK; Go A; Parameswaran KN; Wang YS; Kopple KD
Int J Pept Protein Res; 1986 Oct; 28(4):428-36. PubMed ID: 3793373
[TBL] [Abstract][Full Text] [Related]
24. New 21- and 24-atom Aib-containing cyclopeptides.
Jeremic T; Linden A; Heimgartner H
J Pept Sci; 2008 Sep; 14(9):1051-61. PubMed ID: 18523966
[TBL] [Abstract][Full Text] [Related]
25. Cyclic peptides. XIV. Syntheses of [4-l-leucine]-, [4-D-leucine]-, and [3-L-proline, 4-D-leucine]-Cyl-2.
Yasutake A; Aoyagi H; Sada I; Kato T; Izumiya N
Int J Pept Protein Res; 1982 Sep; 20(3):246-53. PubMed ID: 7129757
[TBL] [Abstract][Full Text] [Related]
26. Studies on cyclic peptides. IV. Conformation of cyclo(Sar-Sar-Gly)2, cyclo(Sar)6, and cyclo(Sar-Gly-Gly)2 and their conformational change induced by alkali thiocyanates.
Sugihara T; Imanishi T; Higashimura T
Biopolymers; 1976 Aug; 15(8):1529-42. PubMed ID: 963248
[No Abstract] [Full Text] [Related]
27. Peptide conformation. 48. Conformation and biological activity of proline containing cyclic retro-analogues of somatostatin.
Kessler H; Klein M; Wagner K
Int J Pept Protein Res; 1988 May; 31(5):481-98. PubMed ID: 2900820
[TBL] [Abstract][Full Text] [Related]
28. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
29. Calcium binding cyclic hexapeptide. Crystal structure of cyclo-(L-prolyl-glycyl)3 calcium complex.
Varughese KI; Aimoto S; Kartha G
Int J Pept Protein Res; 1986 Feb; 27(2):118-22. PubMed ID: 3699982
[TBL] [Abstract][Full Text] [Related]
30. Redox-active bis-cysteinyl peptides. I. Synthesis of cyclic cystinyl peptides by conventional methods in solution and on solid supports.
Musiol HJ; Siedler F; Quarzago D; Moroder L
Biopolymers; 1994 Nov; 34(11):1553-62. PubMed ID: 7827266
[TBL] [Abstract][Full Text] [Related]
31. Coarse-grained molecular dynamics study of cyclic peptide nanotube insertion into a lipid bilayer.
Hwang H
J Phys Chem A; 2009 Apr; 113(16):4780-7. PubMed ID: 19035669
[TBL] [Abstract][Full Text] [Related]
32. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
[TBL] [Abstract][Full Text] [Related]
33. Conformations of psi [CH2NH] pseudopeptides. Cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro]-TFA and cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro].
Ma S; Spatola AF
Int J Pept Protein Res; 1993 Feb; 41(2):204-6. PubMed ID: 8458694
[TBL] [Abstract][Full Text] [Related]
34. Multiple interconverting conformers of the cyclic tetrapeptide tentoxin, [cyclo-(L-MeAla1-L-Leu2-MePhe[(Z) delta]3-Gly4)], as seen by two-dimensional 1H-nmr spectroscopy.
Pinet E; Neumann JM; Dahse I; Girault G; André F
Biopolymers; 1995 Aug; 36(2):135-52. PubMed ID: 7492742
[TBL] [Abstract][Full Text] [Related]
35. Predicting the conformational states of cyclic tetrapeptides.
Loiseau N; Gomis JM; Santolini J; Delaforge M; André F
Biopolymers; 2003 Jul; 69(3):363-85. PubMed ID: 12833263
[TBL] [Abstract][Full Text] [Related]
36. For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides.
Torrini I; Zecchini GP; Paradisi MP; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
Biopolymers; 1995 Apr; 35(4):347-58. PubMed ID: 7711275
[TBL] [Abstract][Full Text] [Related]
37. Molecular conformation and packing of peptide beta hairpins in the solid state: structures of two synthetic octapeptides containing 1-aminocycloalkane-1-carboxylic acid residues at the i+2 position of the beta turn.
Harini VV; Aravinda S; Rai R; Shamala N; Balaram P
Chemistry; 2005 Jun; 11(12):3609-20. PubMed ID: 15812872
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
39. Peptide ionophores: synthesis and cation-binding properties of a bicyclic peptide containing glycine and lysine residues.
Crusi E; Giralt E; Andreu D
Pept Res; 1995; 8(2):62-9. PubMed ID: 7655187
[TBL] [Abstract][Full Text] [Related]
40. Carrier design: conformational studies of amino acid (X) and oligopeptide (X-DL-Alam) substituted poly (L-lysine).
Mezö G; Kajtár J; Hudecz F; Szekerke M
Biopolymers; 1993 Jun; 33(6):873-85. PubMed ID: 8318662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
